Nancy Goodyear
University of Massachusetts Lowell
29 Papers
128 Citations
Nancy Goodyear is an academic researcher from University of Massachusetts Lowell. The author has contributed to research in topics: Certification & Medicine. The author has an hindex of 9, co-authored 23 publications. Previous affiliations of Nancy Goodyear include Children's National Medical Center & George Washington University.
Chat about Author
Papers
Variation in detection limits between bacterial growth phases and precision of an ATP bioluminescence system.
TL;DR: The results suggest that organism identification and growth phase both impact ATP RLU readings, and the precision is adequate with most values within the 95% confidence interval.
26
The effectiveness of three home products in cleaning and disinfection of Staphylococcus aureus and Escherichia coli on home environmental surfaces.
TL;DR: Products included conventional, conventional, environmentally preferable, do‐it‐yourself, 24‐h old DIY, and individual DIY components in dilution for cleaning effectiveness on two common household surfaces and disinfection effectiveness against two common bacteria.
23
A 2-year study of Gram stain competency assessment in 40 clinical laboratories
TL;DR: A computer-based competency assessment tool for Gram stain interpretation is used to assess the performance of 278 laboratory staff from 40 laboratories on 40 multiple-choice questions and helps laboratories identify areas for continuing education in Gram Stain interpretation.
15
Identification of a 37 kDa tacrolimus, sirolimus and cyclosporine binding immunophilin possessing glyceraldehyde 3-phosphate dehydrogenase activity isolated from the Jurkat T cell line.
Jayasimha N. Murthy,Nancy Goodyear,Nancy Goodyear,Steven J. Soldin,Steven J. Soldin,Steven J. Soldin +5 more
TL;DR: The amino acid analysis, protein sequences, binding properties and G3PD activity indicate that this 37 kDa immunophilin is different from any other known Immunophilins.
14
Comparison of binding characteristics of four rapamycin metabolites to the 14 and 52 kDa immunophilins with their pharmacologic activity measured by the mixed-lymphocyte culture assay
Nancy Goodyear,Jayasimha N. Murthy,Heather L. Gallant,Randall W. Yatscoff,Steven J. Soldin,Steven J. Soldin,Steven J. Soldin +6 more
TL;DR: It is demonstrated that the RRA for these four RAPA metabolites shows little cross-reactivity, and provides an excellent way to rapidly assess efficacy/toxicity of R APA in patients receiving the drug.
14